(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VIRTIS HEALTH INNOVATORS IN POST-ACUTE CARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

VIRTIS HEALTH INNOVATORS IN POST-ACUTE CARE

ST13

US500000087918449

Class

35, 44

Filing

87918449

Registration

6411669

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

07/06/2026

Trademark type

Combined

Nice classes

35, 44

Filing date

05/11/2018

Registration date

07/06/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/06/2021

Last transaction

07/06/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/01/2018

First use in commerce

05/01/2018

Drawing code

5

Owner type

03

Owner location

NASHUA, NH, US

Examiner

DEAN, JULES J.

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "VIRTIS" in capital letters in the color blue overtop the word "HEALTH" in capital letters in the color orange with a stylized "A" over top of the words "Innovators in Post-Acute Care" in the color black.

Holders and representatives

Holders

VIRTIS HEALTH HOLDINGS, INC.
Virtis Clinical Holdings, Inc.

Representatives

Daniel Mullarkey POLSINELLI PC

Technical classification

Nice Classes

Class 35Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Medical servicesmedical billing and medical referrals; Business management of infusion services for physicians and nurse practitioners; Business management of physician and nurse practitioner practices; Retail pharmacy servicespreparation and dispensing of medications

Class 44

Medical servicesmedical diagnostic testing services and medical treatment services; healthcare services in the nature of infusion therapy services; healthcare services in the nature of in-home medical infusion therapy services; healthcare services in the nature of providing and administering infusion biologics therapies for transplantimmunologyneurology and hematology; healthcare services in the nature of immunization services; healthcare services in the nature of bio-immunization programs; health care management servicesproviding therapy specific management programs to patients using self- injectable medications; healthcare infusion management services for physicians and advanced nurse practitioner; Dispensing of pharmaceuticals; Health care consulting in the field of prescription drug management; Medical Clinical outcome serviceshealth assessment services; providing continuum-of-care healthcare services and medical facilities; medical evaluation servicesdeveloping and implementing disease management and treatment protocols and patient outcome analysis services

Publications

History of USPTO decisions and trademark events.

47 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/06/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/05/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/11/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/06/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/04/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/03/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/05/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/04/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

05/04/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/04/2021

GNFR

FINAL REFUSAL E-MAILED

03/04/2021

CNFR

SU - FINAL REFUSAL - WRITTEN

03/04/2021

EEXT

SOU TEAS EXTENSION RECEIVED

02/22/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/08/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/08/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/05/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/30/2020

GNRT

NON-FINAL ACTION E-MAILED

11/30/2020

CNRT

SU - NON-FINAL ACTION - WRITTEN

11/30/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/05/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/19/2020

IUAF

USE AMENDMENT FILED

10/05/2020

EISU

TEAS STATEMENT OF USE RECEIVED

10/05/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/25/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/30/2020

PUBO

PUBLISHED FOR OPPOSITION

06/30/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/10/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/26/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

05/26/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/26/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

05/26/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/26/2020

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

04/29/2020

ALIE

ASSIGNED TO LIE

04/27/2020

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

09/27/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/27/2019

GNSL

LETTER OF SUSPENSION E-MAILED

03/27/2019

CNSL

SUSPENSION LETTER WRITTEN

03/27/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/12/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/12/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/12/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/12/2018

GNRT

NON-FINAL ACTION E-MAILED

09/12/2018

CNRT

NON-FINAL ACTION WRITTEN

09/12/2018

DOCK

ASSIGNED TO EXAMINER

09/04/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/20/2018

NWAP

NEW APPLICATION ENTERED

05/15/2018

Continuous trademark protection

Get notified about every new filing that threatens VIRTIS HEALTH INNOVATORS IN POST-ACUTE CARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.